Chandan Healthcare Share Price Today

Chandan Healthcare settles Dayal Institute dispute

Dayal Institute of Medical Sciences withdraws its complaint against Chandan Healthcare after settling disputes over alleged financial irregularities. The resolution, confirmed on July 31, 2026, closes proceedings with SEBI, NSE, and the Registrar of Companies, removing regulatory uncertainty for the diagnostics firm.

Chandan Healthcare holds analysts' and investors' meeting

Chandan Healthcare Limited conducted a virtual analysts' and investors' meeting on June 30, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, attended by 32 participants including institutional investors and HNIs, followed a Q&A format with no presentation. No Unpublished Price Sensitive Information was shared during the session.

Chandan Healthcare FY26 PAT rises 21.4% to ₹27.06 Cr

Chandan Healthcare reported a 21.4% increase in reported net profit to ₹27.06 Cr for FY26, while total income rose 20.4% to ₹280.67 Cr. EBITDA grew 31% to ₹56.84 Cr, driven by improved operating leverage. The company serves 62 cities across 16 states with a balanced B2C, B2B, and B2G revenue model.

Chandan Healthcare faces ROC notice over complaint

Chandan Healthcare Limited faces a regulatory notice from the ROC regarding a complaint alleging financial mismanagement and fraud. The complaint, backed by a forensic audit, cites bogus expenditures of over ₹7.6 crore and misrepresentation in financial statements. The company has been directed to respond within a stipulated timeline to avoid action under the Companies Act, 2013.

Chandan Healthcare FY26 PAT rises 22% to ₹27.06 Cr

Chandan Healthcare reported a 22.04% increase in PAT to ₹27.06 Cr for FY26, with total income rising 20.43% to ₹280.67 Cr. EBITDA grew 31.02% to ₹56.84 Cr, with margins expanding 164 basis points to 20.25%. The company expanded its network with new centres and franchises, secured government PPP projects worth ₹800 Cr, and outlined future growth pillars including a genome lab and aggressive franchise scaling.

Chandan Healthcare reappoints auditors for FY27

Chandan Healthcare Limited reappointed M/s. Renu Agrawal & Co. as statutory auditor and M/s. Rahul Jain & Associates as cost auditor for FY27. The decisions were made in a board meeting on May 29, 2026. Both firms will serve a one-year term.